Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis

Pulmonary Pharmacology & Therapeutics
Gustavo J Rodrigo, Luís J Nannini

Abstract

Current guidelines recommend the use of inhaled tiotropium in patients with stable chronic obstructive pulmonary disease (COPD). However, this statement is based on a relatively small number of randomized controlled trials (RCTs) and related systematic reviews. This review was undertaken to incorporate the more recent evidence available about the effectiveness of tiotropium bromide compared with placebo, iptratropium bromide or long-acting beta-agonists (LABAs), for the treatment of stable COPD patients. Medline, EMBASE, CINAHL, and the Cochrane Controlled Trials Register (to February 2006) were searched to identify all published RCTs. We also searched bibliographies of relevant articles. Data from 13 RCT (6078 subjects, 80% male) showed that tiotropium reduced COPD-related exacerbations (OR=0.76; 95% CI: 0.68-0.87) and hospital admissions (OR=0.59; 95% CI: 0.47-0.73) compared with placebo. Also, tiotropium showed statistically significant improvement in lung function, including trough, average, and peak FEV(1) and FVC from baseline, compared with placebo and ipratropium. The administration of inhaled tiotropium lead to 30% reduction in COPD-related admissions (OR= 0.67; 95% CI: 0.46-0.98) compared with LABAs. Finally, increase...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Feb 16, 2000·Chest·P J Barnes
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·M R LittnerT J Witek
Feb 28, 2002·The European Respiratory Journal·R CasaburiT Witek
May 10, 2002·The European Respiratory Journal·J A van NoordP J G Cornelissen
May 15, 2002·Chest·Marc MiravitllesUNKNOWN DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Sep 26, 2003·Respiratory Medicine·J F DonohueS Kesten
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Don D SinNick R Anthonisen
Aug 2, 2005·The European Respiratory Journal·J A van NoordP J G Cornelissen
Sep 24, 2005·Pulmonary Pharmacology & Therapeutics·D D BriggsC Cassino

❮ Previous
Next ❯

Citations

Mar 26, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Alexandros G MathioudakisGeorgios A Mathioudakis
May 6, 2008·Proceedings of the American Thoracic Society·Philip T DiazByron M Thomashow
Aug 7, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Daniel E HillemanDan Schuller
Aug 18, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Eric BatemanRick Hodder
Sep 22, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Kazuhito AsanoHiroaki Nakajima
Jun 7, 2011·Clinical Evidence·Robert Andrew McIvorDavid Charles Todd
Oct 18, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Isao SuzakiHarumi Suzaki
Jun 10, 2009·Expert Opinion on Drug Safety·Pierachille Santus, Fabiano Di Marco
May 8, 2008·Chest·Gustavo J RodrigoRoberto Rodríguez-Roisin
Nov 17, 2011·Pulmonary Pharmacology & Therapeutics·Gustavo J RodrigoJosé A Castro-Rodríguez
Jul 8, 2008·British Journal of Pharmacology·M Cazzola, M G Matera
Dec 14, 2006·Expert Opinion on Pharmacotherapy·Laura MeinkeGanesh Krishna
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Colin R DormuthGreg Carney
Mar 22, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Colin R DormuthGreg Carney
Oct 30, 2008·The Annals of Pharmacotherapy·Andrea M ChenPatrick M Finnegan
Feb 22, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Michael Dreher, Hans-Joachim Kabitz
Feb 9, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Paul A CafarellaPeter A Frith
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Ivone M FerreiraRoger Goldstein
Apr 9, 2011·Postgraduate Medicine·Barry Make, Mark H Belfer
Jan 15, 2015·Journal of Medicinal Chemistry·Paolo Montuschi, Giovanni Ciabattoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.